Euclidean Capital LLC
An institutional investment manager in NEW YORK, NY. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1825034.
- Reported value$439.8m
- Positions11
Holdings: 11 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Vanguard International Equity Index F | ALLWRLD EX US | 922042775 | 272 | 61.8% | 3,243,484 | Unchanged | |
| Vanguard Index FDS | VALUE ETF | 922908744 | 113 | 25.8% | 520,000 | Unchanged | |
| Ishares TR | MSCI INDIA ETF | 46429B598 | 18.3 | 4.2% | 369,600 | Unchanged | |
| Oric Pharmaceuticals IncORIC | COM | 68622P109 | 10.7 | 2.4% | 989,410 | Unchanged | |
| Teamshares IncTMS | COM | 87821B109 | 9.0 | 2.1% | 1,099,974 | New+1,099,974 | |
| Foghorn Therapeutics IncFHTX | COM | 344174107 | 7.7 | 1.7% | 1,573,761 | Unchanged | |
| PMV Pharmaceuticals IncPMVP | COM | 69353Y103 | 3.5 | 0.8% | 2,627,643 | Unchanged | |
| Alector IncALEC | COM | 014442107 | 2.6 | 0.6% | 1,307,858 | Unchanged | |
| Surrozen IncSRZN | COM NEW | 86889P208 | 2.3 | 0.5% | 87,696 | Unchanged | |
| Tenaya Therapeutics IncTNYA | COM | 87990A106 | 0.8 | 0.2% | 1,015,705 | Unchanged | |
| Surrozen Inc | *W EXP 08/01/203 | 86889P117 | 0.0 | <0.1% | 170,833 | Unchanged |
Source: SEC EDGAR, Form 13F-HR, accession 0001012975-26-000776 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.